PharmaceuticalsRSS feed

The following Reckon news items have been filed under Pharmaceuticals.

Tue 01 Apr 2008AG opinion in son-of-Syfait ECJ case
Wed 16 Jan 2008Dawn raids for pharmaceutical sector inquiry
Tue 11 Dec 2007OFT conclusions on UK medicines distribution
Tue 03 Jul 2007AstraZeneca delays new UK distribution arrangements
Mon 23 Apr 2007AstraZeneca UK appoints AAH and Unichem as distributors
Wed 04 Apr 2007OFT market study on pharmaceutical wholesaling
Tue 20 Mar 2007AAH & others v Pfizer & Unichem [2007] EWHC 565 (Ch)
Wed 14 Mar 2007GSK predatory abuse on hospital antibiotics in France
Fri 23 Feb 2007Report by the Patient Power Review Group
Tue 20 Feb 2007OFT review of UK pharmaceutical price regulation (PPRS)
Thu 14 Dec 2006Department of Health guidelines on car parking charges
Tue 31 Oct 2006Test version of NHS "payment by results" tariff 2007/2008
Wed 18 Oct 2006Government response to the Health Committee's report on NHS charges
Fri 29 Sep 2006On-going work by the Patient Power Review Group
Wed 27 Sep 2006Prohibition of GSK anti-parallel-trade measures quashed
Wed 26 Jul 2006Health Committee report on ISTC programme
Tue 18 Jul 2006Health Select Committee report on NHS charges
Tue 11 Jul 2006ECJ judgment on Fenin (concept of undertaking)
Wed 26 Apr 2006Details of alleged Losec abuse by AstraZeneca
Wed 19 Apr 2006Updated guidance on 2006 NHS reference cost collection
Thu 13 Apr 2006Healthcare at Home claims damages from Genzyme
Thu 06 Apr 2006NHS reference costs 2004/2005
Thu 23 Mar 2006OFT inquiry into pharmaceutical price regulation
Wed 18 Jan 2006Ofcom case closure: Patientline competition law investigation
Mon 14 Nov 2005Fenin Advocate General opinion (concept of undertaking)
Thu 13 Oct 2005Health Committee inquiry on NHS co-payments and charges
Thu 29 Sep 2005Genzyme Limited v Office of Fair Trading [2005] CAT 32
Tue 13 Sep 2005OFT launches market study into PPRS
Mon 12 Sep 2005"Standard" branded generic medicines excluded from PPRS
Thu 28 Oct 2004Advocate General opinion in Syfait parallel trade case
Tue 08 May 2001Prohibition of GSK dual pricing in Spain (2001)

Reckon LLP is an economics consultancy with expertise in data analysis, economic regulation and competition law.

About Reckon